What Are The Absolute And Relative Contraindications To Consider When Selecting Candidates For Ablative Laser Resurfacing Procedures? Essential Safety Guide For Choosing Ideal Candidates

Ablative laser resurfacing requires both safety screening and expectation management. Absolute contraindications generally include active infection in the treatment area, unrealistic expectations, inability to follow postoperative wound-care instructions, and recent systemic isotretinoin use, particularly for deep or fully ablative procedures. Relative contraindications include abnormal scarring, impaired healing, collagen-vascular disease, prior radiation or deep tissue injury, pregnancy or breastfeeding, active koebnerizing dermatoses, and increased dyschromia risk in darker phototypes.

The contraindication is not determined by diagnosis alone. It depends on whether the treatment is full-field or fractional, superficial or deep, the treatment site, the patient’s healing capacity, and whether the risk can be reduced through delay, medical optimization, prophylaxis, conservative settings, or an alternative procedure.

Absolute Contraindications That Usually Require Deferral

Active infection in the treatment area

Active bacterial, viral, or fungal infection should be treated and resolved before resurfacing. This includes active herpes simplex, impetigo, cellulitis, and other infections affecting the intended treatment zone.

Ablation disrupts the epidermal barrier and can worsen infection, delay re-epithelialization, or facilitate dissemination. Patients with recurrent herpes labialis are not automatically excluded, but they generally require antiviral prophylaxis according to the treating clinician’s protocol.

Inability to perform postoperative wound care

Ablative resurfacing creates a controlled wound that requires cleansing, moisture management, infection surveillance, sun avoidance, and follow-up. An inability or unwillingness to comply makes treatment unsafe and is an absolute contraindication until the issue is resolved.

This includes practical barriers such as inadequate support, inability to attend follow-up, or misunderstanding of the recovery process.

Unrealistic expectations

Patients expecting poreless skin, complete scar removal, permanent correction, or a complication-free recovery are poor candidates. Treatment should be deferred until the expected benefits, limitations, downtime, and risks are understood.

This is not merely a communication concern; unrealistic expectations can lead to dissatisfaction, premature additional procedures, or unsafe pressure to increase treatment intensity.

Recent systemic isotretinoin use

Recent oral isotretinoin or related systemic retinoid therapy is a major concern for deep or fully ablative resurfacing because of potential effects on sebaceous structures, re-epithelialization, and scarring risk.

The appropriate interval is modality- and treatment-dependent. A commonly used precaution is to defer deep ablative treatment for at least 6–12 months, while some protocols use longer intervals—up to 1–2 years—after extensive full-field treatment. The decision should be individualized rather than applied as a universal rule to every fractional procedure.

Relative Contraindications Requiring Risk Modification

History of keloids or hypertrophic scars

A personal tendency toward keloid or hypertrophic scarring increases the risk of abnormal healing. The risk is especially important when the proposed treatment is deep, full-field, or performed in a high-risk anatomic area.

This is generally a relative contraindication in candidate selection, although some clinicians may treat a history of significant facial keloids as a practical or absolute contraindication. If treatment is considered, counseling, conservative parameters, and—where appropriate—a test spot may be necessary.

Previous impaired wound healing

A history of delayed healing, wound breakdown, severe scarring, or complications after surgery or resurfacing suggests increased risk. The underlying cause should be identified before treatment.

Potential contributors include uncontrolled diabetes, active immunosuppression, smoking or nicotine exposure, poor nutritional status, and certain systemic diseases or medications.

Collagen-vascular and systemic inflammatory disease

Active systemic lupus erythematosus, scleroderma, systemic vasculitis, or other collagen-vascular disease may impair healing or increase inflammation and photosensitivity. Treatment should generally be deferred until disease activity, medications, and healing capacity have been reviewed.

Stable disease is not necessarily an automatic exclusion, but it requires coordination with the relevant medical specialist when appropriate.

Prior radiation or severe tissue injury

Previously irradiated skin may have compromised vascularity and reduced or absent appendageal structures, including hair follicles and sebaceous glands. These structures provide cells important for epidermal regeneration.

Prior deep chemical peels, dermabrasion, burns, or deep laser treatment can create similar concerns. Treatment over such areas may be unsuitable or require substantially more conservative planning.

Active koebnerizing skin disorders

Active vitiligo, psoriasis, lichen planus, and some cases of severe eczema can worsen after cutaneous trauma through the Koebner phenomenon. Resurfacing should be postponed when disease is active or unstable.

A remote history does not carry the same risk as active disease, but it still requires counseling and careful monitoring.

Pregnancy and breastfeeding

Pregnancy and breastfeeding are commonly treated as relative contraindications because elective ablative resurfacing has no urgent medical benefit and safety data are limited. Deferral is usually the most prudent approach.

Any associated medications, anesthetics, antivirals, antibiotics, or analgesics must also be reviewed for pregnancy and lactation compatibility.

Darker skin phototypes and dyschromia risk

Fitzpatrick IV–VI skin types, and any patient with a history of post-inflammatory hyperpigmentation, have a higher risk of persistent hyperpigmentation or other postoperative dyschromia.

Fractional and more superficial approaches may reduce—but do not eliminate—this risk. Full-field deep resurfacing requires particularly careful justification, conservative settings, strict sun avoidance, and informed consent.

Inability to avoid postoperative sun exposure

Ultraviolet exposure during healing increases the risk of persistent erythema, hyperpigmentation, and uneven results. Patients who cannot reliably avoid intense sun exposure or use appropriate photoprotection may need to postpone treatment.

This is especially important for patients with darker phototypes or a history of pigmentary complications.

High-risk eyelid anatomy

Treatment near the eyelids requires additional assessment in patients with eyelid laxity, prior external blepharoplasty, or other eyelid-support abnormalities. Tissue contraction after ablative treatment can contribute to lower-lid malposition or ectropion.

This is a site-specific relative contraindication and may warrant an alternative treatment, reduced treatment intensity, or specialist assessment.

Screening Issues That Are Not Automatically Contraindications

A history of herpes simplex

A prior history of herpes labialis is not usually an exclusion by itself. However, ablative treatment can reactivate herpes in the treated area, so clinicians commonly consider antiviral prophylaxis beginning before treatment and continuing through re-epithelialization.

The exact regimen should follow local protocol and patient-specific medical assessment.

Smoking and nicotine exposure

Smoking and secondhand smoke can impair tissue oxygenation and wound healing through vasoconstriction and other effects. Nicotine exposure should be addressed as a modifiable risk factor before treatment.

In patients undergoing extensive resurfacing or with other healing risks, treatment may be postponed until meaningful cessation is achieved.

Systemic disease and medications

Uncontrolled diabetes, significant cardiovascular disease, uncontrolled hypertension, active immunosuppression, and photosensitizing medications may increase procedural risk. These conditions are not all universal contraindications, but they require medical optimization and individualized risk assessment.

The clinician should review medications, immune status, prior procedures, infection history, and the patient’s ability to heal before selecting treatment depth and modality.

Understanding the Trade-offs

Full-field versus fractional treatment

Full-field ablative resurfacing generally produces more dramatic resurfacing but creates a larger continuous wound and carries greater risks of infection, delayed healing, scarring, and dyschromia.

Fractional treatment leaves intervening untreated skin and may improve healing and broaden candidacy, but it does not eliminate contraindications or guarantee safe treatment in high-risk patients.

CO₂ versus Er:YAG treatment

CO₂ and Er:YAG systems differ in tissue interaction, thermal effect, and achievable treatment depth. Contraindication decisions should therefore account for the specific device, settings, density, number of passes, and anatomic site rather than relying only on the word “laser.”

A superficial fractional procedure and a deep full-field procedure should not be treated as equivalent interventions.

“Relative” does not mean “safe”

A relative contraindication means that treatment may be possible under selected circumstances—not that the risk is minor. It may instead require disease control, a longer medication washout, prophylaxis, test spots, lower energy, reduced density, or a different modality.

Screening cannot remove every complication

Even an ideal candidate can develop infection, prolonged erythema, pigment alteration, acne or milia, delayed healing, scarring, or ocular complications. Consent should address both common recovery effects and less frequent serious complications.

How to Apply This to Candidate Selection

The final decision should be made after reviewing the patient, treatment site, laser modality, and intended depth together.

If your primary focus is infection prevention: Defer treatment for any active infection, assess herpes history, and use appropriate antiviral or antimicrobial management when clinically indicated.
If your primary focus is wound healing: Avoid or delay treatment after recent systemic isotretinoin, and investigate scarring history, radiation, deep prior procedures, smoking, diabetes, immunosuppression, and collagen-vascular disease.
If your primary focus is pigment safety: Use particular caution in Fitzpatrick IV–VI skin types and patients with prior hyperpigmentation; consider fractional or superficial treatment rather than deep full-field ablation.
If your primary focus is patient satisfaction: Confirm realistic expectations, informed consent, willingness to avoid sun exposure, and ability to complete postoperative wound care before scheduling.
If your primary focus is anatomic safety: Exercise additional caution around the eyelids, especially with eyelid laxity or prior external blepharoplasty, and consider specialist evaluation.

Safe candidate selection is the process of matching the patient’s healing capacity and risk profile to the least aggressive treatment capable of achieving the intended goal.

Summary Table:

Contraindication	Type	Key Considerations
Active infection in treatment area	Absolute	Treat infection first; risk of worsening or dissemination.
Inability to perform wound care	Absolute	Must be able to follow post-op care and follow-up.
Unrealistic expectations	Absolute	Defer until expectations are aligned with realistic outcomes.
Recent systemic isotretinoin use	Absolute	Defer deep ablative treatment for at least 6-12 months.
History of keloids/hypertrophic scars	Relative	Consider test spot, conservative parameters.
Impaired wound healing	Relative	Identify and manage underlying causes (e.g., diabetes, smoking).
Collagen-vascular disease	Relative	Assess disease activity and coordinate with specialist.
Prior radiation or severe injury	Relative	May require conservative approach or alternative treatment.
Active koebnerizing dermatoses	Relative	Defer until disease is stable.
Pregnancy/breastfeeding	Relative	Usually defer; review medication compatibility.
Darker skin types (IV-VI)	Relative	Higher dyschromia risk; use fractional or superficial settings.
Inability to avoid sun exposure	Relative	Postpone if adherence not possible.
High-risk eyelid anatomy	Relative	Assess laxity; may need specialist evaluation.

Elevate your clinic's aesthetic standards with BELIS' professional-grade laser systems. Our advanced technologies, including CO2 fractional and Er:YAG lasers, are designed for safe and effective resurfacing when candidates are carefully selected. Our team of experts can guide you in optimizing treatment protocols and patient safety. Contact our specialists today to learn how BELIS can support your practice and enhance patient outcomes. Get in touch now!